Pet predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease
Academic Article
Overview
MeSH Major
Antineoplastic Combined Chemotherapy Protocols
Fluorodeoxyglucose F18
Hodgkin Disease
Lymphoma, Non-Hodgkin
Tomography, Emission-Computed
abstract
(18)F-FDG PET after 1 cycle of chemotherapy is predictive of 18-mo outcome in patients with aggressive NHL and HD and may earlier identify patients who would benefit from more intensive treatment programs.
